Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1059839
Reference Type
Journal Article
Title
The relationship between CD86/CD54 expression and THP-1 cell viability in an in vitro skin sensitization test--human cell line activation test (h-CLAT)
Author(s)
Sakaguchi, H; Ashikaga, T; Miyazawa, M; Kosaka, N; Ito, Y; Yoneyama, K; Sono, S; Itagaki, H; Toyoda, H; Suzuki, H
Year
2009
Is Peer Reviewed?
Yes
Journal
Cell Biology and Toxicology
ISSN:
0742-2091
EISSN:
1573-6822
Publisher
Springer Science+Business Media
Volume
25
Issue
2
Page Numbers
109-126
Language
English
PMID
18204907
DOI
10.1007/s10565-008-9059-9
Web of Science Id
WOS:000263826300002
Abstract
Recent regulations for cosmetics in Europe prohibit animal testing for evaluating the sensitization potential of chemicals to improve animal welfare. Yet, there is not an acceptable Organization for Economic Co-operation and Development non-animal skin sensitization test method. Several in vitro skin sensitization methods that focus on the activation of Langerhans cells, including human cell lines, are being evaluated as possible alternatives. In our previous study, we optimized our human cell line activation test (h-CLAT) using THP-1 cells (monocytic leukemia cell line) and conducted an inter-laboratory study. We found that measuring CD86/CD54 expression may be useful for predicting skin sensitization. The aim of this study was to confirm the relationship between CD86/CD54 expression and THP-1 cell viability in the h-CLAT. In this study, 21 allergens (e.g., dinitrochlorobenzene, p-phenylenediamine, Ni) and 8 non-allergens (e.g., SLS, lactic acid) were evaluated. For each chemical, more than 10 concentrations that gave a predicted cell viability range of 20-95% were used. The data showed that expression patterns of CD86/CD54 differed depending on chemical. For most allergens, cytotoxicity (65-90% cell viability) was needed for enhancement of CD86/CD54 expression. The criteria of "CD86 > or = 150 or CD54 > or = 200" resulted in an accuracy of 93%, which confirms appropriate cut-off criteria for h-CLAT. Furthermore, a good correlation was observed between EC3 of local lymph node assay and EC150(CD86) or EC200(CD54) of h-CLAT (12 or 16 chemicals, respectively), which would provide a useful estimate of allergic potency. These findings suggest that h-CLAT would be a good robust in vitro skin sensitization test.
Keywords
Tumor cell lines; Cytotoxicity; Skin tests; Local lymph node assay; Allergens; Monocytic leukemia; Economics; Lactic acid; CD86 antigen; Animal welfare; Langerhans cells; Cosmetics; Data processing; Skin; Cell activation
Tags
PPRTV
•
1,3-Dinitrobenzene 2021
Literature Search June 2021
Scopus (July 2021)
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity